June 2025 in “British Journal of Dermatology” In this case report, the temporal relationship between starting dupilumab treatment and the onset of psoriasis in an adult with atopic dermatitis suggests that dupilumab may contribute to psoriatic lesions, and dermatologists should consider psoriasis a potential adverse event of the medication.
June 2025 in “Preprints.org” In this retrospective case series, baricitinib showed effectiveness in treating severe alopecia areata but had mixed results for psoriasis and was not optimal for psoriatic arthritis in patients with coexisting conditions, suggesting further studies are needed.
June 2025 in “Dermatopathology” This study reports that SARS-CoV-2 infection, COVID-19 vaccination, and off-label dupilumab treatment may exacerbate psoriasis, with overlapping inflammatory pathways involving cytokines like IL-17 and TNF-α. Histopathological similarities between psoriasis flares and COVID-19 skin manifestations were noted, suggesting a potential connection requiring further research.
May 2025 in “Skin Appendage Disorders” This review reports that psoriatic alopecia, a type of hair loss linked to psoriasis, is difficult to diagnose and often resistant to conventional treatments, highlighting the need for further research into its immune-related mechanisms and personalized treatment approaches for better management.
May 2025 in “JEADV Clinical Practice” This study found that using calcipotriene and betamethasone dipropionate cream in a real-world setting significantly improved clinical outcomes and patient quality of life for adults with mild-to-moderate scalp psoriasis, especially among those with higher adherence, demonstrating high treatment satisfaction.
May 2025 in “Galen Medical Journal” This research highlights advancements in understanding and treating psoriasis, finding that targeted therapies like IL-17 and IL-23 inhibitors show promise, but challenges such as adverse events, treatment resistance, and the need for personalized approaches remain.
March 2025 in “International Journal of Clinical Dermatology” This study proposed a detailed classification of psychodermatosis by examining three cases that illustrate the interaction between the brain and skin, resulting in conditions like trichotillomania and factitious dermatitis.
March 2025 in “Journal of Cosmetic Dermatology” In this case study, a 29-year-old woman with Pseudopelade of Brocq, a type of scarring alopecia, showed significant hair density improvement following a combination of scalp reduction surgery and concentrated growth factor injections postoperatively, which addressed scar complications and inflammation.
February 2025 in “International Journal For Multidisciplinary Research” In this descriptive study conducted in a tertiary care center in Chennai, researchers observed that chemotherapy-induced hair loss seriously impacts the emotional well-being of cancer survivors, especially women and younger individuals, with severity of hair loss correlating strongly with psychological distress.
February 2025 in “JDDG Journal der Deutschen Dermatologischen Gesellschaft” This study reports a case where a patient with both psoriasis and alopecia universalis experienced regrowth of scalp and body hair after treatment with Deucravacitinib, a TYK2 inhibitor, suggesting potential effectiveness but recommending controlled studies to confirm this finding.
January 2025 in “International Journal of Molecular Sciences” This narrative review explored the complex interconnections between psoriasis and other dermatological conditions like vitiligo, alopecia areata, and atopic dermatitis, highlighting shared immune dysfunctions that complicate diagnosis and treatment, with implications for research and holistic patient care.
This case report describes a 28-year-old woman who developed alopecia areata following prolonged emotional stress, with improvement observed using Minoxidil and stress management, but relapse occurred after another stressful period.
January 2025 in “TURKDERM” This study observed that patients with alopecia areata had higher psychological distress levels and distinct neurotrophin serum levels compared to healthy controls, suggesting a relationship between psychological factors and neurotrophins in the disease's pathology.
Emotional states significantly affect hair growth and hair disorders.
This review reports that androgenetic alopecia in young adult men is consistently linked to lower self-esteem, increased anxiety, and a higher risk of depression, suggesting significant psychosocial impacts beyond cosmetic concerns.
January 2025 in “Actas Dermo-Sifiliográficas” Hair transplants improve self-esteem and quality of life in women with hair loss.
January 2025 in “Dermatology Review” This paper outlines the clinical features of artefactual skin disorder, emphasizing the complexities in diagnosing the self-inflicted lesions that patients deny, and underscores the importance of integrating dermatological, psychiatric, and psychological treatment approaches.
January 2025 in “Trepo - Institutional Repository of Tampere University” Alopecia areata significantly harms women's self-image, causing reduced confidence and social isolation.
January 2025 in “Indian Journal of Small Ruminants (The)” In this case study of a Beetal doe with severe skin lesions, the researchers diagnosed concurrent psoroptic mange and malasseziosis, and reported successful treatment with a combination of Ivermectin, antibiotics, and topical applications, leading to reduced skin lesions and new hair growth.
Understanding both skin and mental health aspects of alopecia areata is crucial for better patient care.
December 2024 in “Annals of Medicine and Surgery” Early diagnosis of pseudopelade of Brocq in men is crucial to prevent permanent hair loss.
December 2024 in “Journal of Population Therapeutics and Clinical Pharmacology” According to this worldwide systematic review, psoriasis is a prevalent disease with adult prevalence ranging from 0.53% to 11.48%, more common in older populations and with substantial knowledge gaps in low and middle-income countries.
December 2024 in “Ukrains kyi Visnyk Psykhonevrolohii” This study found that women with mixed alopecia experienced significant cognitive impairments, particularly those with adaptation disorders, with symptoms like rapid fatigue and impaired concentration being most prevalent. The cognitive patterns are complex and require further investigation to inform tailored rehabilitation strategies.
December 2024 in “JDDG Journal der Deutschen Dermatologischen Gesellschaft” In this case report, researchers observed hair regrowth in a patient with alopecia universalis and psoriasis after treatment with deucravacitinib, a TYK2 inhibitor, though they note spontaneous regrowth cannot be ruled out and suggest further controlled studies to evaluate its effects on alopecia areata.
Psoriasis patients should do moderate exercise like walking or yoga for 30 minutes, 4-5 times a week.
November 2024 in “Medicina Estética Revista Científica de la Sociedad Española de Medicina Estética (SEME)” In this case report, a 58-year-old woman was diagnosed with pseudopelada of Brocq, highlighting the diagnostic challenges of this rare scarring alopecia and underscoring the need for precise evaluation using trichoscopy and skin biopsy to avoid ineffective treatments and manage progression.
November 2024 in “Psychology Health & Medicine” This study identified subgroups of people with alopecia areata with varying levels of quality of life impairment, influenced by feelings of flaw, coping styles, and social factors.
November 2024 in “Journal of Investigative Dermatology” Polygenic Score can help predict severe psoriasis and psoriatic arthritis.
November 2024 in “Actas Dermo-Sifiliográficas”
October 2024 in “World Journal of Psychiatry” In this study, patients with androgenetic alopecia experiencing stress had higher cortisol levels and altered neurotrophic factors compared to non-stressed patients, which correlated with more severe hair loss progression even after minoxidil treatment.